ACVECC抗血栓药物合理使用共识(CURATIVE)指南在小动物病例中的临床应用
本文以病例为基础,阐述如何将ACVECC抗血栓药物合理使用共识(CURATIVE)指南应用于有血栓风险的犬猫。犬猫血栓风险源于多种疾病,常涉及特定损伤后的炎症反应,并与高凝状态、血管内皮损伤、血流动力学改变等因素共同作用。诊断血栓仍具挑战性,需结合临床症状、已知风险因素和支持性诊断试验。治疗推荐依据CURATIVE指南第2和第3领域,讨论抗血栓药物选择与剂量方案,并酌情纳入治疗监测(第4领域)和停药(第5领域)。遵循共识可能改善总体预后,但对结局的影响需进一步研究。
要点
- 犬猫血栓风险源于多种疾病,常为特定损伤后炎症反应合并高凝状态、血管内皮损伤和血流动力学改变等促成因素。
- 小动物血栓诊断仍具挑战性,兼容的临床症状、已知风险因素和支持性诊断试验可高度提示血栓形成。
- 治疗推荐依据CURATIVE指南第2和第3领域,围绕抗血栓药物选择与剂量方案展开。
- 酌情纳入CURATIVE指南第4领域(治疗监测)和第5领域(抗血栓药物停药)的相关内容。
- 遵循CURATIVE共识推荐可能改善有血栓风险小动物的总体预后,但对结局的影响需进一步研究。
适用人群与场景
- 有血栓形成风险的犬和猫。
处置流程与药物剂量
- 抗血栓药物选择与剂量方案参照CURATIVE指南第2和第3领域,具体病例中描述。
- 酌情依据CURATIVE指南第4领域进行治疗监测。
- 酌情依据CURATIVE指南第5领域停用抗血栓药物。
研究设计与关键结果
- 本文为病例系列文章,通过具体病例展示CURATIVE指南在有血栓风险犬猫中的应用,讨论抗血栓药物选择、剂量方案、治疗监测和停药。
- 犬猫血栓风险源于多种疾病,常涉及特定损伤后的炎症反应,并与高凝状态、血管内皮损伤、血流动力学改变等促成因素共同作用。
- 小动物血栓诊断仍具挑战性,兼容的临床症状、已知风险因素和支持性诊断试验可高度提示血栓形成。
- 遵循CURATIVE共识推荐可能改善有血栓风险小动物的总体预后,但对结局的影响需进一步研究。
证据类型、等级与局限
- 证据类型:病例系列文章,基于CURATIVE指南的病例应用。
- 局限:原文未报告局限性
对床旁实践的改变
- 对有血栓风险的犬猫,可参照CURATIVE指南第2和第3领域选择抗血栓药物及剂量方案。
- 在抗血栓治疗过程中,可酌情参照CURATIVE指南第4领域进行治疗监测。
- 在抗血栓治疗过程中,可酌情参照CURATIVE指南第5领域决定停药。
- 遵循CURATIVE共识推荐可能改善有血栓风险小动物的总体预后,但对结局的影响需进一步研究。
指南或共识出处
- ACVECC抗血栓药物合理使用共识(CURATIVE)指南
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To illustrate the application of the Consensus on the Rational Use of Antithrombotics in Veterinary Critical Care (CURATIVE) guidelines to the management of dogs and cats at risk of developing thrombosis using a case-based approach.
ETIOLOGY: Dogs and cats become at risk of developing thrombosis from a wide range of conditions. These conditions often involve a specific insult followed by an inflammatory response and when combined with other contributing factors (eg, hypercoagulability, vascular endothelial injury, hemodynamic changes) create favorable conditions for thrombosis.
DIAGNOSIS: Development of thrombosis in small animals remains challenging to demonstrate. Compatible clinical signs, the presence of known risk factors, and supporting diagnostic tests may be highly suggestive of the development of thrombosis.
THERAPY: Therapeutic recommendations in accordance with the CURATIVE guidelines for dogs and cats are described in specific case vignettes presented. Discussion is centered on antithrombotic drug choices and dosing protocols, as outlined in Domains 2 and 3 of the CURATIVE guidelines. Where appropriate, guidelines related to therapeutic monitoring (Domain 4) and discontinuation of antithrombotics (Domain 5) were included.
PROGNOSIS: In small animals at risk of developing thrombosis, overall prognosis may be improved by following consensus-based recommendations on the use of antithrombotics as outlined in the CURATIVE guidelines. Whether such interventions have any impact on outcome requires further investigation.
参考来源
- Sharp CR, Goggs R, Blais MC, et al. Clinical application of the American College of Veterinary Emergency and Critical Care (ACVECC) Consensus on the Rational Use of Antithrombotics in Veterinary Critical Care (CURATIVE) guidelines to small animal cases. J Vet Emerg Crit Care (San Antonio). 2019. PMID: 30729652. doi:10.1111/vec.12804
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。